Vident Advisory’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.63M Buy
16,114
+9,371
+139% +$4.72M 0.06% 253
2025
Q4
$3.15M Buy
6,743
+2,474
+58% +$1.15M 0.03% 442
2025
Q3
$1.82M Buy
4,269
+793
+23% +$307K 0.02% 606
2025
Q2
$1.33M Sell
3,476
-10,436
-75% -$3.76M 0.02% 631
2025
Q1
$4.81M Buy
13,912
+11,963
+614% +$3.85M 0.07% 247
2024
Q4
$585K Buy
1,949
+147
+8% +$51.4K 0.01% 865
2024
Q3
$733K Buy
1,802
+131
+8% +$48K 0.02% 748
2024
Q2
$537K Buy
1,671
+23
+1% +$7.47K 0.01% 839
2024
Q1
$550K Buy
1,648
+82
+5% +$25.1K 0.01% 784
2023
Q4
$424K Buy
1,566
+57
+4% +$14.1K 0.01% 849
2023
Q3
$371K Buy
+1,509
New +$413K 0.01% 805

Other funds holding HCA

Vident Advisory's HCA Position: Q1 2026 in Review

Vident Advisory increased its HCA Healthcare (HCA) stake by 139% in Q1 2026, buying an estimated $4.72M and bringing the position to 16,114 shares worth $7.63M. The position accounts for 0.06% of the portfolio, ranked #253.

Vident Advisory first reported a position in HCA in Q3 2023 and has held it in 11 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Vident Advisory held 16,114 shares of HCA Healthcare worth $7.63M as of Q1 2026.
  • Vident Advisory bought 9,371 HCA Healthcare shares in Q1 2026, an estimated $4.72M.
  • HCA Healthcare made up 0.06% of Vident Advisory's portfolio in Q1 2026, its #253 holding.
  • Vident Advisory first reported a position in HCA Healthcare in Q3 2023 and has held it in 11 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.